Skip to content
OpenCapital
Get started

Pediatrix Medical Group MD Share Repurchase Program, Remaining Authorized, Amount

Share Repurchase Program, Remaining Authorized, Amount at other companies

ICU Medical logo
ICU MedicalICUI
——

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%
Enterprise value$2.41B+22.3%
P/E11.4×—
P/S1×+0.3×

Profitability

See full
Operating margin11.3%—
Net margin9%—
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%—
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's share repurchase program, remaining authorized, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's share repurchase program, remaining authorized, amount?
Pediatrix Medical Group (MD) reported share repurchase program, remaining authorized, amount of $146.3M in Q1 2026.
What is the long-term trend for Pediatrix Medical Group's share repurchase program, remaining authorized, amount?
Over 3 years (2020 to 2024), Pediatrix Medical Group's share repurchase program, remaining authorized, amount has grown at a -69.1% compound annual growth rate (CAGR), from $98.7M to $2.9M.